DE60037195D1 - Verbindungen zur behandlung von infektionskrankheiten und störungen des immunsystems sowie methoden ihrer anwendung - Google Patents

Verbindungen zur behandlung von infektionskrankheiten und störungen des immunsystems sowie methoden ihrer anwendung

Info

Publication number
DE60037195D1
DE60037195D1 DE60037195T DE60037195T DE60037195D1 DE 60037195 D1 DE60037195 D1 DE 60037195D1 DE 60037195 T DE60037195 T DE 60037195T DE 60037195 T DE60037195 T DE 60037195T DE 60037195 D1 DE60037195 D1 DE 60037195D1
Authority
DE
Germany
Prior art keywords
disorders
compounds
treatment
methods
application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60037195T
Other languages
English (en)
Other versions
DE60037195T2 (de
Inventor
Alain Delcayre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genesis Research and Development Corp Ltd
Original Assignee
Genesis Research and Development Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genesis Research and Development Corp Ltd filed Critical Genesis Research and Development Corp Ltd
Priority claimed from PCT/NZ2000/000121 external-priority patent/WO2001004140A1/en
Publication of DE60037195D1 publication Critical patent/DE60037195D1/de
Application granted granted Critical
Publication of DE60037195T2 publication Critical patent/DE60037195T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60037195T 1999-07-12 2000-07-10 Verbindungen zur behandlung von infektionskrankheiten und störungen des immunsystems sowie methoden ihrer anwendung Expired - Fee Related DE60037195T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US351348 1982-02-22
US09/351,348 US6436898B1 (en) 1999-07-12 1999-07-12 Compounds for treatment of infectious and immune system disorders and methods for their use
US450072 1999-11-29
US09/450,072 US6358734B1 (en) 1999-07-12 1999-11-29 Compounds for treatment of infectious and immune system disorders and methods for their use
PCT/NZ2000/000121 WO2001004140A1 (en) 1999-07-12 2000-07-10 Compounds for treatment of infectious and immune system disorders and methods for their use

Publications (2)

Publication Number Publication Date
DE60037195D1 true DE60037195D1 (de) 2008-01-03
DE60037195T2 DE60037195T2 (de) 2008-10-02

Family

ID=23380534

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60037195T Expired - Fee Related DE60037195T2 (de) 1999-07-12 2000-07-10 Verbindungen zur behandlung von infektionskrankheiten und störungen des immunsystems sowie methoden ihrer anwendung

Country Status (5)

Country Link
US (2) US6436898B1 (de)
KR (1) KR20020025187A (de)
CN (1) CN1800210A (de)
AR (1) AR025198A1 (de)
DE (1) DE60037195T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2383496A1 (en) * 1999-07-12 2001-01-18 Genesis Research & Development Corporation Limited Compounds for treatment of infectious and immune system disorders and methods for their use
CN107099603A (zh) * 2017-05-31 2017-08-29 成都克里斯博生物科技有限公司 肿瘤免疫t细胞检测试剂盒和检测方法

Also Published As

Publication number Publication date
AR025198A1 (es) 2002-11-13
US6436898B1 (en) 2002-08-20
CN1800210A (zh) 2006-07-12
DE60037195T2 (de) 2008-10-02
KR20020025187A (ko) 2002-04-03
US6358734B1 (en) 2002-03-19

Similar Documents

Publication Publication Date Title
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE542801T1 (de) Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
ATE296634T1 (de) (s,s)-reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen
DE69903543D1 (de) Formulierungen zur behandlung von magen-speiseröhren reflux
ATE202940T1 (de) Mittel und methoden zur behandlung von plaque- krankheiten
DE60138129D1 (de) Apparat zur behandlung von zähnen
DE69325222D1 (de) Verfahren zur behandlung infektiöser krankheiten, verfahren zur verhinderung des verderbs von kosmetika, antibakterielle und schimmelhemmende mittel sowie kosmetika
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
ATE201992T1 (de) Carbostyrilderivat zur behandlung von ophthalmologischen erkrankungen
DE60014876D1 (de) Verbindungen und verfahren zur behandlung von asthma, allergie und entzündlichen erkrankungen
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE69620691T2 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE60136748D1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE69735162D1 (de) L-carnosin enthaltende mittel zur behandlung des nierenversagens
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE59914712D1 (de) Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden
DE60127552D1 (de) Intrakorporelle medikamente zur hoch-energetischen phototherapeutischen behandlung von krankheiten
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE299371T1 (de) Antikonvulsiva zur behandlung von autismus
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee